Studies have been undertaken to judge the effectiveness of Acthar® Gel (repository corticotropin injection [RCI]) in the tetrodotoxin (TTX) model of early-life-induced epileptic spasms. Repository corticotropin injection (RCI) is broadly used in the United States to deal with childish spasms. A serious element of RCI is N25 deamidated ACTH. Additionally, we hoped to supply some perception into the attainable function circulating corticosteroids play in spasm cessation by evaluating the RCI dose-response relationships for spasm suppression to RCI-induced corticosterone launch from the adrenal gland. Spasms have been induced by persistent TTX infusion into the neocortex starting on postnatal day 11.
Repository corticotropin injection (RCI) dosages have been between Eight and 32 IU/kg/day. Drug titration protocols have been used, and comparisons have been made to injections of a automobile gel. Video/EEG recordings (24/7) monitored the drug’s results repeatedly for as much as 2 months. Tetrodotoxin (TTX)-infused management rats have been monitored for a similar interval of time. In separate experiments, the identical dosages of RCI got to rats and 1 h later plasma was collected and assayed for corticosterone. The value of care included MS-related inpatient, outpatient, and remedy prices. Treatment response was outlined as no proof of extra relapse therapy or process claims inside 30 days after therapy.
A parallel examine in contrast the consequences of 1-day and 10-day RCI remedies on circulating corticosterone. Results confirmed that RCI was ineffective at dosages of 8, 12, and 16 IU/kg/day however eradicated spasms in 66% of animals handled with 24 or 32 IU/kg/day. Treating animals with 32 IU/kg/day alone produced the identical diploma of spasms suppression as noticed throughout the titration protocols. In rats that had hypsarrhythmia-like exercise, RCI eradicated this irregular interictal EEG sample in all rats that grew to become seizure-free. In phrases of plasma corticosterone, 1- and 10-day remedies with RCI produced comparable will increase in this hormone and the degrees elevated linearly with rising dosages of RCI.
This stood in sharp distinction to the sigmoid-like dose-response curve for decreases in spasm counts. Our outcomes additional validate the TTX model as related for the examine of childish spasms. The model ought to be helpful for investigating how RCI acts to get rid of seizures and hypsarrhythmia. Dose-response outcomes recommend that both very excessive concentrations of circulating corticosteroids are required to abolish spasms or RCI acts by a distinct mechanism. In the oblique remedy comparability of six eligible scientific trial research, the chances of attaining efficacy outcomes have been 5 to eight instances larger with RCI than with tetracosactide and 14 to 16 instances larger than CCMC.
A Systematic Literature Review and Indirect Treatment Comparison of Efficacy of Repository Corticotropin Injection versus Synthetic Adrenocorticotropic Hormone for Infantile Spasms
Infantile spasms is a uncommon illness characterised by distinct seizures and hypsarrhythmia. Adrenocorticotropic hormone (ACTH) is on the market as a pure product (repository corticotropin injection, [RCI]; Acthar® Gel) and as artificial analogs. RCI is a naturally-sourced advanced combination of purified ACTH analogs and different pituitary peptides accredited by the United States Food and Drug Administration as a monotherapy for the remedy of childish spasms. RCI is usually used in the United States. Outside the United States, artificial analogs of ACTH-synthetic ACTH1-24 (tetracosactide) and artificial ACTH1-39 (corticotropin carboxymethyl-cellulose [CCMC])-are used.
The efficacy of RCI could differ from that of artificial ACTH remedies primarily based on the construction of peptide; nonetheless, no head-to-head scientific trials have in contrast the efficacy of RCI and artificial ACTH remedies. A scientific overview and oblique remedy comparability of scientific trials was carried out to evaluate the comparative efficacy of RCI and artificial ACTH remedies in childish spasms.
A search was carried out in MEDLINE, EMBASE, and Cochrane databases by September 30, 2020. Relevant scientific trials on RCI or artificial ACTH remedy and reporting both cessation of spasms or decision of hypsarrhythmia, individually or as a mixed final result have been included. A Bayesian oblique remedy comparability utilizing a fixed-effects model was used for comparative efficacy. Of 473 citations screened, 21 research have been reviewed qualitatively. This translated to a threat discount of 10% to 14% and 40% to 50% with RCI versus tetracosactide and CCMC, respectively.
For each two to 5 sufferers handled, RCI improved efficacy outcomes in one extra affected person in comparison with artificial ACTH (adjusted quantity needed-to-treat).Based on the out there restricted proof, outcomes recommend RCI could also be extra efficacious for childish spasms than artificial ACTH remedies. Our findings present a blueprint to tell the design of future potential research for the remedy of childish spasms.
Quality evaluation of real-world knowledge repositories throughout the info life cycle: A literature overview
Data high quality (DQ) have to be constantly outlined in context. The attributes, metadata, and context of longitudinal real-world knowledge (RWD) haven’t been formalized for high quality enchancment throughout the info manufacturing and curation life cycle. We sought to finish a literature overview on DQ evaluation frameworks, indicators and instruments for analysis, public well being, service, and high quality enchancment throughout the info life cycle. The overview adopted PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) pointers.
Databases from well being, bodily and social sciences have been used: Cinahl, Embase, Scopus, ProQuest, Emcare, PsycINFO, Compendex, and Inspec. Embase was used as an alternative of PubMed (an interface to go looking MEDLINE) as a result of it consists of all MeSH (Medical Subject Headings) phrases used and journals in MEDLINE in addition to extra distinctive journals and convention abstracts. A mixed knowledge life cycle and high quality framework guided the search of revealed and grey literature for DQ frameworks, indicators, and instruments. At least 2 authors independently recognized articles for inclusion and extracted and categorized DQ ideas and constructs. All authors mentioned findings iteratively till consensus was reached.
AAV2 Null Control Virus |
|||
| AAV-352 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Null (empty) control virus of AAV serotype 2. |
|||
AAV1-Luc Control Virus |
|||
| AAV-321 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Luciferase control virus of AAV serotype 1. |
|||
AAV3-Luc Control Virus |
|||
| AAV-323 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Luciferase control virus of AAV serotype 3. |
|||
AAV4-Luc Control Virus |
|||
| AAV-324 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Luciferase control virus of AAV serotype 4. |
|||
AAV5-Luc Control Virus |
|||
| AAV-325 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Luciferase control virus of AAV serotype 5. |
|||
AAV6-Luc Control Virus |
|||
| AAV-326 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Luciferase control virus of AAV serotype 6. |
|||
Positive control tissue section for each antibody; Based on availability INQUIRE |
|||
| Control-Slides | Innovex | Set of 5 | EUR 176 |
AAV2 antibody |
|||
| 10R-A111a | Fitzgerald | 50 ug | EUR 589 |
|
Description: Mouse monoclonal AAV2 antibody |
|||
AAV2 antibody |
|||
| 10R-A140a | Fitzgerald | 50 ug | EUR 682 |
|
Description: Mouse monoclonal AAV2 antibody |
|||
AAV1-GFP Control Virus |
|||
| AAV-301 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: GFP control virus of AAV serotype 1. |
|||
AAV3-GFP Control Virus |
|||
| AAV-303 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: GFP control virus of AAV serotype 3. |
|||
AAV4-GFP Control Virus |
|||
| AAV-304 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: GFP control virus of AAV serotype 4. |
|||
AAV5-GFP Control Virus |
|||
| AAV-305 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: GFP control virus of AAV serotype 5. |
|||
AAV6-GFP Control Virus |
|||
| AAV-306 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: GFP control virus of AAV serotype 6. |
|||
AAV1-Cre Control Virus |
|||
| AAV-311 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Cre control virus of AAV serotype 1. |
|||
AAV3-Cre Control Virus |
|||
| AAV-313 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Cre control virus of AAV serotype 3. |
|||
AAV4-Cre Control Virus |
|||
| AAV-314 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Cre control virus of AAV serotype 4. |
|||
AAV5-Cre Control Virus |
|||
| AAV-315 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Cre control virus of AAV serotype 5. |
|||
AAV6-Cre Control Virus |
|||
| AAV-316 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Cre control virus of AAV serotype 6. |
|||
scAAV1-GFP Control Virus |
|||
| AAV-331 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Self-complementary GFP control virus of AAV serotype 1. |
|||
scAAV2-GFP Control Virus |
|||
| AAV-332 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Self-complementary GFP control virus of AAV serotype 2. |
|||
scAAV3-GFP Control Virus |
|||
| AAV-333 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Self-complementary GFP control virus of AAV serotype 3. |
|||
scAAV4-GFP Control Virus |
|||
| AAV-334 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Self-complementary GFP control virus of AAV serotype 4. |
|||
scAAV5-GFP Control Virus |
|||
| AAV-335 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Self-complementary GFP control virus of AAV serotype 5. |
|||
scAAV6-GFP Control Virus |
|||
| AAV-336 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Self-complementary GFP control virus of AAV serotype 6. |
|||
AAV1-LacZ Control Virus |
|||
| AAV-341 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: LacZ control virus of AAV serotype 1. |
|||
AAV3-LacZ Control Virus |
|||
| AAV-343 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: LacZ control virus of AAV serotype 3. |
|||
AAV4-LacZ Control Virus |
|||
| AAV-344 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: LacZ control virus of AAV serotype 4. |
|||
AAV5-LacZ Control Virus |
|||
| AAV-345 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: LacZ control virus of AAV serotype 5. |
|||
AAV6-LacZ Control Virus |
|||
| AAV-346 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: LacZ control virus of AAV serotype 6. |
|||
AAV1 Null Control Virus |
|||
| AAV-351 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Null (empty) control virus of AAV serotype 1. |
|||
AAV3 Null Control Virus |
|||
| AAV-353 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Null (empty) control virus of AAV serotype 3. |
|||
AAV4 Null Control Virus |
|||
| AAV-354 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Null (empty) control virus of AAV serotype 4. |
|||
AAV5 Null Control Virus |
|||
| AAV-355 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Null (empty) control virus of AAV serotype 5. |
|||
AAV6 Null Control Virus |
|||
| AAV-356 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Null (empty) control virus of AAV serotype 6. |
|||
pRedZeo-CMV Virus [positive control] |
|||
| SR10046VA-1 | SBI | >2 x 10^6 IFUs | EUR 689 |
pRedTK-CMV Virus [positive control] |
|||
| SR10052VA-1 | SBI | >2 x 10^6 IFUs | EUR 689 |
pGreenZeo-mCMV Virus [negative control] |
|||
| SR500VA-1 | SBI | >2 x 10^6 IFUs | EUR 672 |
pGreenZeo-CMV Virus [positive control] |
|||
| SR501VA-1 | SBI | >2 x 10^6 IFUs | EUR 672 |
Human Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E01A0397-192T | BlueGene | 192 tests | EUR 1270 |
|
Description: A competitive ELISA for quantitative measurement of Human Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E01A0397-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
|
Description: A competitive ELISA for quantitative measurement of Human Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E08A0397-192T | BlueGene | 192 tests | EUR 1270 |
|
Description: A competitive ELISA for quantitative measurement of Canine Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E08A0397-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
|
Description: A competitive ELISA for quantitative measurement of Canine Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E08A0397-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
|
Description: A competitive ELISA for quantitative measurement of Canine Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E09A0397-192T | BlueGene | 192 tests | EUR 1270 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E09A0397-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E09A0397-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E02A0397-192T | BlueGene | 192 tests | EUR 1270 |
|
Description: A competitive ELISA for quantitative measurement of Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E02A0397-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
|
Description: A competitive ELISA for quantitative measurement of Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E02A0397-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
|
Description: A competitive ELISA for quantitative measurement of Rat Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E07A0397-192T | BlueGene | 192 tests | EUR 1270 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E07A0397-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E07A0397-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E04A0397-192T | BlueGene | 192 tests | EUR 1270 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E04A0397-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E04A0397-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E06A0397-192T | BlueGene | 192 tests | EUR 1270 |
|
Description: A competitive ELISA for quantitative measurement of Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E06A0397-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
|
Description: A competitive ELISA for quantitative measurement of Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E06A0397-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
|
Description: A competitive ELISA for quantitative measurement of Goat Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E03A0397-192T | BlueGene | 192 tests | EUR 1270 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E03A0397-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E03A0397-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Guinea pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E05A0397-192T | BlueGene | 192 tests | EUR 1270 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Guinea pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E05A0397-48 | BlueGene | 1 plate of 48 wells | EUR 520 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Guinea pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) ELISA kit |
|||
| E05A0397-96 | BlueGene | 1 plate of 96 wells | EUR 685 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Adeno Associated Virus type 2 Antibody (AAV2-Ab) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Vaccinia virus Complement control protein C3 (VACWR025) |
|||
| 1-CSB-YP302389VAI | Cusabio |
|
|
|
Description: Recombinant Vaccinia virus Complement control protein C3(VACWR025) expressed in Yeast |
|||
Influenza A virus HA Control/blocking peptide |
|||
| AB-23091-P | Alpha Diagnostics | 100ug | EUR 164 |
pBV-Luc |
|||
| PVT12245 | Lifescience Market | 2 ug | EUR 703 |
pMR-Luc |
|||
| PVT14074 | Lifescience Market | 2 ug | EUR 703 |
pT7- Luc |
|||
| PVT10670 | Lifescience Market | 2 ug | EUR 301 |
pSBE- Luc |
|||
| PVT10816 | Lifescience Market | 2 ug | EUR 301 |
pTRE3G- LUC |
|||
| PVT10818 | Lifescience Market | 2 ug | EUR 301 |
pAP1- Luc |
|||
| PVT10819 | Lifescience Market | 2 ug | EUR 301 |
pHSE- Luc |
|||
| PVT10820 | Lifescience Market | 2 ug | EUR 266 |
pGRE- luc |
|||
| PVT10821 | Lifescience Market | 2 ug | EUR 266 |
pCRE- Luc |
|||
| PVT10825 | Lifescience Market | 2 ug | EUR 301 |
pViperin- Luc |
|||
| PVT10826 | Lifescience Market | 2 ug | EUR 301 |
pTA- Luc |
|||
| PVT10827 | Lifescience Market | 2 ug | EUR 301 |
pTAL- Luc |
|||
| PVT10829 | Lifescience Market | 2 ug | EUR 301 |
pIRF3- Luc |
|||
| PVT10830 | Lifescience Market | 2 ug | EUR 301 |
p53- Luc |
|||
| PVT10836 | Lifescience Market | 2 ug | EUR 266 |
Baboon Anti-Rabies Virus IgG antiserum negative control |
|||
| 600-070-03N | Alpha Diagnostics | 1 ml | EUR 164 |
Baboon Anti-Rabies Virus IgG antiserum positive control |
|||
| 600-070-04P | Alpha Diagnostics | 1 ml | EUR 225 |
Purified Nipah virus Glycoprotein control for Western Blotting |
|||
| NIV11-C | Alpha Diagnostics | 100 ul | EUR 286 |
Purified Nipah virus Nucleoprotein control for Western Blotting |
|||
| NIV21-C | Alpha Diagnostics | 100 ul | EUR 225 |
pCDH-Cuo-RFP-T2A-GFP (positive control virus) |
|||
| QM350VA-1 | SBI | >1 x 10^6 IFUs | EUR 636 |
β-Lactamase (Luciferase) lentiviral particles |
|||
| LVP335-luc | GenTarget | 1x107 IFU/ml x 200ul | EUR 349 |
|
Description: pre-made lentiviral particles expressing β-Lactamase gene. A firefly luciferase marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. |
|||
A549 / Luciferase (Puromycin) stable cell line |
|||
| SC043-Luc | GenTarget | 2 x 106 cell/ml x 1ml | EUR 920 |
|
Description: Luciferase (firefry) expression stable cell line in A549 human cancer cell line with Puromycin marker. |
|||
Human AsPC1 / Luciferase Cell Line |
|||
| SC062-Luc | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1500 |
|
Description: Firefly luciferase expression stable cell line in Human AsPC1 cells with Puromycin resistance |
|||
mouse MOPC315 / Luciferase Cell Line |
|||
| SC063-Luc | GenTarget | 2 x 106 cell/ml x 1ml | EUR 2225 |
|
Description: Firefly luciferase expression stable cell line in mouse MOPC315 cells with Puromycin resistance |
|||
Huamn SW403 / Luciferase Stable Cells |
|||
| SC067-Luc | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1500 |
|
Description: Firefly luciferase expression stable cell line in human SW403 cells with Puromycin resistance |
|||
Human PANC-1 / Luciferase (Puro) Cell Line |
|||
| SC068-Luc | GenTarget | 2 x 106 cell/ml x 1ml | EUR 2225 |
|
Description: Firefly luciferase expression stable cell line in Human PANC-1 cells with Puromycin resistance |
|||
pNF-kB-Luc |
|||
| PVT1322 | Lifescience Market | 2 ug | EUR 325 |
pGL3-ELAM-Luc |
|||
| PVT14533 | Lifescience Market | 2 ug | EUR 599 |
proE-cad178-Luc |
|||
| PVT14614 | Lifescience Market | 2 ug | EUR 599 |
pSynSRE-T-Luc |
|||
| PVT14626 | Lifescience Market | 2 ug | EUR 703 |
p21-Luc Plasmid |
|||
| PVTB00035-2c | Lifescience Market | 2 ug | EUR 356 |
IgK- IFN- luc |
|||
| PVT10425 | Lifescience Market | 2 ug | EUR 266 |
pNFAT- TA- Luc |
|||
| PVT10808 | Lifescience Market | 2 ug | EUR 266 |
pE2F- TA- Luc |
|||
| PVT10809 | Lifescience Market | 2 ug | EUR 266 |
pISRE- TA- Luc |
|||
| PVT10810 | Lifescience Market | 2 ug | EUR 266 |
pGAS- TA- Luc |
|||
| PVT10811 | Lifescience Market | 2 ug | EUR 266 |
pP53- TA- luc |
|||
| PVT10814 | Lifescience Market | 2 ug | EUR 301 |
pStat3- TA- luc |
|||
| PVT10815 | Lifescience Market | 2 ug | EUR 301 |
pHes1 (2.5k)- Luc |
|||
| PVT10832 | Lifescience Market | 2 ug | EUR 266 |
pHes1 (467)- luc |
|||
| PVT10833 | Lifescience Market | 2 ug | EUR 266 |
pUC57-Tac-Luc |
|||
| PVT18215 | Lifescience Market | 2 ug | EUR 258 |
Human Anti-Mumps Virus (parotitis) IgG negative control serum |
|||
| 520-100-01N | Alpha Diagnostics | 1 ml | EUR 164 |
Human Anti-Mumps Virus (parotitis) IgG positive control serum |
|||
| 520-100-02P | Alpha Diagnostics | 1 ml | EUR 225 |
Mouse Anti-Mumps Virus (parotitis) IgG negative control serum |
|||
| 520-130-05N | Alpha Diagnostics | 1 ml | EUR 164 |
Mouse Anti-Mumps Virus (parotitis) IgG positive control serum |
|||
| 520-130-06P | Alpha Diagnostics | 1 ml | EUR 225 |
Monkey Anti-Mumps Virus (parotitis) IgG negative control serum |
|||
| 520-160-03N | Alpha Diagnostics | 1 ml | EUR 164 |
Monkey Anti-Mumps Virus (parotitis) IgG positive control serum |
|||
| 520-160-04P | Alpha Diagnostics | 1 ml | EUR 225 |
Rhesus Monkey Anti-Rabies Virus IgG antiserum negative control |
|||
| 600-070-01N | Alpha Diagnostics | 1 ml | EUR 164 |
Rhesus Monkey Anti-Rabies Virus IgG antiserum positive control |
|||
| 600-070-02P | Alpha Diagnostics | 1 ml | EUR 225 |
Monkey (Cynomolgous) Anti-Rabies Virus IgG antiserum negative control |
|||
| 600-070-05N | Alpha Diagnostics | 1 ml | EUR 164 |
Cynos Monkey Anti-Rabies Virus IgG antiserum positive control |
|||
| 600-070-06P | Alpha Diagnostics | 1 ml | EUR 225 |
Camelpox virus H3L/p35 protein control for western blot |
|||
| CPOX11-C | Alpha Diagnostics | 100 ul | EUR 286 |
Control/Blocking peptide for Tobacco Mosaic Virus Movement Protein |
|||
| TMVMP11-P | Alpha Diagnostics | 100 ug | EUR 164 |
Zika Virus prM Protein (African) control for Western blot |
|||
| ZPRM11-C | Alpha Diagnostics | 100 ul | EUR 286 |
Mayaro virus (MAYV) Capsid Protein control for Western Blotting |
|||
| MAYV31-C | Alpha Diagnostics | 100 ul | EUR 286 |
Mayaro virus (MAYV) nsP1 protein control for Western Blotting |
|||
| MAYV41-C | Alpha Diagnostics | 100 ul | EUR 286 |
Mayaro virus (MAYV) 6K Protein control for Western Blotting |
|||
| MAYV51-C | Alpha Diagnostics | 100 ug | EUR 286 |
Mayaro virus (MAYV) E3 protein control for Western Blotting |
|||
| MAYV61-C | Alpha Diagnostics | 100 ul | EUR 286 |
pGreenPuro Scramble Hairpin Control - Virus (for shRNAs and miRZips) |
|||
| MZIP000-VA-1 | SBI | >1 x 10^6 IFUs | EUR 716 |
Recombinant Polyoma Virus (KV, Pneumotropic virus) Capsid Protein 1 (VP1) control for Western blot |
|||
| KVP14-C | Alpha Diagnostics | 100 ul | EUR 286 |
PinPoint Donor Positive Control Vector: CM->Luciferase (pPP-CMV-Luc-pA-attB-Puro-pA) |
|||
| PIN610A-1 | SBI | 10ug | EUR 1023 |
Mouse Anti-Respiratory syncytial virus (RSV) IgG negative control serum |
|||
| 510-345-01N | Alpha Diagnostics | 1 ml | EUR 164 |
Mouse Anti-Respiratory syncytial virus (RSV) IgG positive control serum |
|||
| 510-345-02P | Alpha Diagnostics | 1 ml | EUR 225 |
Baboon Anti-Rabies Virus Glycoprotein (RVG) IgG antiserum negative control |
|||
| 600-180-01N | Alpha Diagnostics | 1 ml | EUR 164 |
Baboon Anti-Rabies Virus Glycoprotein (RVG) IgG antiserum positive control |
|||
| 600-180-02P | Alpha Diagnostics | 1 ml | EUR 225 |
Rabies Virus Glycoprotein (~58 kda, RVG) control for western blot |
|||
| RBVGP11-C | Alpha Diagnostics | 100 ul | EUR 286 |
Bovine Anti-Lumpy skin disease virus (LSDV) negative control serum |
|||
| RV-500700-01N | Alpha Diagnostics | 1 ml | EUR 164 |
Bovine Anti-Lumpy skin disease virus (LSDV) positive control serum |
|||
| RV-500700-02P | Alpha Diagnostics | 1 ml | EUR 225 |
Recombinant Rat sialodacryoadenitis Virus (SDAV) nucleoprotein control for Western blot |
|||
| SDAV11-C | Alpha Diagnostics | 100 ul | EUR 286 |
Bovine Lumpy skin disease virus (LSDV) control for western blot |
|||
| LSDV11-C | Alpha Diagnostics | 100 ul | EUR 286 |
Influenza A virus (H5N1) matrix protein 2 Control/blocking peptide |
|||
| M2E15-P | Alpha Diagnostics | 100 ug | EUR 164 |
Influenza A virus (H1N1) matrix protein 2 Control/blocking peptide |
|||
| M2E16-P | Alpha Diagnostics | 100 ug | EUR 164 |
Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide |
|||
| M2E17-P | Alpha Diagnostics | 100 ug | EUR 164 |
Simian virus 5 (starin W3) P/V Control/blocking peptide |
|||
| AB-23077-P | Alpha Diagnostics | 100ug | EUR 164 |
Camel Anti-Camelpox virus H3L/p35 IgG negative control serum |
|||
| AE-311170-01N | Alpha Diagnostics | 1 ml | EUR 164 |
Camel Anti-Camelpox virus H3L/p35 IgG positive control serum |
|||
| AE-311170-02P | Alpha Diagnostics | 1 ml | EUR 225 |
Human Anti-Respiratory syncytial virus (RSV) IgG Negative Control Serum |
|||
| 510-300-01N | Alpha Diagnostics | 1 ml | EUR 164 |
Monkey Anti-Respiratory syncytial virus (RSV) IgG Negative Control Serum |
|||
| 510-325-01N | Alpha Diagnostics | 1 ml | EUR 164 |
Monkey Anti-Respiratory syncytial virus (RSV) IgG Positive Control Serum |
|||
| 510-325-02P | Alpha Diagnostics | 1 ml | EUR 225 |
The 120 included articles yielded ideas associated to contextual (knowledge supply, custodian, and consumer) and technical (interoperability) elements throughout the info life cycle. Contextual DQ subcategories included relevance, usability, accessibility, timeliness, and belief. Well-tested computable DQ indicators and evaluation instruments have been additionally discovered. A DQ evaluation framework that covers intrinsic, technical, and contextual classes throughout the info life cycle permits evaluation and administration of RWD repositories to make sure health
